查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
前列腺肥大症治療設備的全球市場:至2028年的預測，COVID-19影響與市場分析:各產品，手術各類型，各終端用戶，各地區
市場調查報告書
商品編碼
1118338

前列腺肥大症治療設備的全球市場:至2028年的預測，COVID-19影響與市場分析:各產品，手術各類型，各終端用戶，各地區

Benign Prostatic Hyperplasic Devices Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Product, Procedure Type, and End User, and Geography
出版日期: | 出版商: The Insight Partners | 英文 190 Pages | 訂單完成後即時交付

價格

全球前列腺肥大症治療設備的市場規模，2021年是20億7,878萬美金。該市場預計2022年～至2028年，以7.6％的年複合成長率擴大，2028年達到34億6,731萬美元。

本報告提供全球前列腺肥大症治療設備市場相關調查，市場概要，以及各產品，各手術類型，各終端用戶，各地區的趨勢，及加入此市場的主要企業簡介等資訊。

目錄

第1章 簡介

第2章 重要點

第3章 調查手法

第4章 前列腺肥大症治療設備市場-市場形勢

  • PEST分析
  • 專家的見解

第5章 前列腺肥大症治療設備市場-主要的市場動態

  • 市場促進因素
  • 市場阻礙因素
  • 市場機會
  • 今後趨勢
  • 影響分析

第6章 前列腺肥大症治療設備市場-世界分析

  • 全球前列腺肥大症治療設備市場收益預測與分析
  • 全球前列腺肥大症治療設備市場-預測與分析，各地區
  • 全球前列腺肥大症治療設備市場-市場潛在力分析，各地區
  • 企業分析
  • 成長策略分析
  • 主要加入企業的成果

第7章 全球前列腺肥大症治療設備市場收益和至2028年的預測-各產品

  • 前列腺肥大症治療設備市場收益佔有率，各產品(2022年及2028年)
  • 切除鏡子
  • 泌尿系統雷射
  • 高頻燒灼術設備
  • 前列腺支架
  • 植入

第8章 全球前列腺肥大症治療設備市場分析與至2028年的預測- 手術各類型

  • 前列腺肥大症治療設備市場收益佔有率，各手術類型(2022年及2028年)
  • 經尿道微波療法
  • 前列腺的經尿道切除
  • 前列腺的經尿道針切除
  • 雷射手術
  • UroLift手術
  • 其他

第9章 全球前列腺肥大症治療設備市場分析與至2028年的預測-各終端用戶

  • 前列腺肥大症治療設備市場收益佔有率，各終端用戶(2022年及2028年)
  • 醫院
  • 診療所
  • 門診病人手術中心
  • 其他

第10章 前列腺肥大症治療設備市場收益與預測-各地區分析

  • 北美
  • 歐洲
  • 亞太地區
  • 中東、非洲
  • 中南美

第11章 COVID-19大流行對前列腺肥大症治療設備市場的影響

  • 北美
  • 歐洲
  • 亞太地區
  • 中東、非洲
  • 中南美

第12章 前列腺肥大症治療設備市場-產業形勢

第13章 企業簡介

  • KARL STORZ SE & Co. KG
  • Richard Wolf GmbH
  • Olympus Corporation
  • Urologix, LLC.
  • Boston Scientific Corporation
  • Butterfly
  • Teleflex Incorporated
  • OmniGuide Holdings, Inc.
  • Convergent Laser Technologies
  • ProArc

第14章 附錄

Product Code: TIPRE00025704

The global benign prostatic hyperplasic devices market is expected to US$ 2,078.78 million in 2021 to US$ 3,467.31 million by 2028; it is expected to grow with a CAGR of 7.6% from 2022 to 2028.

An increase in the prevalence of benign prostatic hyperplasia along with growing risk factors and a rise in investments, funds, and grants for research in BPH treatment boost the global benign prostatic hyperplasic devices market growth.

Benign prostatic hyperplasia (BPH) is a prostate enlargement caused by excessive cell growth in the prostate. BPH is a benign (non-cancerous) prostate condition. Non-cancerous conditions are not usually fatal and do not spread (metastasize) to other body parts. BPH doesn't raise the risk of prostate cancer; unless it manifests symptoms, BPH isn't considered a health issue. Almost all men will have some prostate growth by the age of 70. Getting older, having more belly fat (also known as abdominal obesity), and not getting enough exercise to raise the risk of developing BPH.

Players operating in the benign prostatic hyperplasic devices industry focus on investing high amounts in the development of advanced surgical technologies as alternatives to conventional techniques. Advanced devices enabled with new technologies help provide immediate relief and reduce morbidity.

In January 2022, ProVerum, a start-up supported by EIT Health, received US$ 31.22 million in Series A funding from Gilde Healthcare, Lightstone Ventures, and Atlantic Bridge. ProVerum, an Irish company, has developed ProVee, a cutting-edge treatment solution for men with symptomatic BPH. The company aims to market its innovative device in the US and Europe with the help of recent funding.

In June 2021, Zenflow, Inc., a medical device company developing a minimally invasive treatment for urinary obstruction caused by BPH or enlarged prostate, declared the completion of its Series B funding round with a total of US$ 24 million. The investment was led by Invus Opportunities and included participation from Medical Technology Venture Partners, F-Prime Capital, CloudStone Capital, Astia Angels, Golden Seeds, SV Tech Ventures, etc.

In June 2021, Procept Biorobotics raised US$ 85 million to commercialize the AquaBeam system as a global BPH treatment. With this product, the company intends to make an impact with its water-based robotic technology in the field of prostate surgery. The series G financing was led by Fidelity Management & Research Company, with additional backing from T. Rowe Price Associates, CPMG, Perceptive Advisors, Viking Global Investors, and Duquesne Family Office.

In July 2019, Medeon Biodesign, Inc, a publicly traded Taiwan medical device company, announced that it recently led and closed an investment in Prodeon. Prodeon is a Taiwan-based company offering a simple, office-based treatment option for patients who need quick relief from LUTS caused due to BPH.

In April 2018, ProVerum Medical closed a US$ 4.2 million seed investment, with Atlantic Bridge University Fund leading the investment round. With this investment, the company aims to commence its first human trials of its product for BPH treatment. This product includes a nitinol implant to dilate the prostatic urethra without altering the structure of the prostate anatomy. The nitinol implant can be manufactured to a small size to simplify the process of implantation through a 10-15-minute long minimally invasive surgery.

In February 2018, Zenflow, a medical device company based in San Francisco, California, announced a US$ 31.4 million Series A investment round for further advancements in its minimally invasive technique for treating BPH or an enlarged prostate.

Product-Based Insights

Based on the product, the benign prostatic hyperplasic devices market is segmented into resectoscopes, radiofrequency ablation devices, urology lasers, prostatic stents, and implants. The resectoscopes segment is likely to hold the largest market share in 2022. However, the urology lasers segment is anticipated to register the highest CAGR during the forecast period due to the high demand by physicians and the rising initiatives of market players in the launch and product expansion.

Procedure Type Insights

Based on procedure type, the benign prostatic hyperplasic devices market is segmented into transurethral microwave therapy, transurethral resection of the prostate, transurethral needle ablation of the prostate, laser surgery, urolift surgery, and others. In 2022, the transurethral resection of the prostate segment is likely to hold the market's largest share. Furthermore, the same segment is expected to witness growth in its demand at the fastest CAGR from 2022 to 2028, owing to its visual, hands-on access to the prostate, ability to the immediate removal of excess tissue, the ability of transurethral resection of the prostate (TURP) to combine with other procedures.

End User-Based Insights

Based on end user, the benign prostatic hyperplasic devices market is segmented into hospitals, clinics, ambulatory surgical centers, and others. In 2022, the hospitals segment is likely to hold the largest share of the market. Moreover, the clinics segment is expected to witness growth in its demand at the fastest CAGR from 2022 to 2028, owing to an increase in the number of clinics at a lower cost for treatment, easy accessibility, and flexibility with the short waiting time.

National Center for Biotechnology Information (NCBI), National Library of Medicine, Indiana University School of Medicine, Centers for Disease Control and Prevention (CDC), Canadian Risk Factor Atlas (CRFA), World Bank, Urology Foundation, International Diabetes Federation (IDF), National Statistics Institute (INE), National Medica Device Promotion Council, International Trade Administration, Department of Emergency Medicine are among the primary and secondary sources referred to while preparing the report on the benign prostatic hyperplasic devices market.

Reasons to Buy:

  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the benign prostatic hyperplasic devices market.
  • Highlights key business priorities in order to assist companies to realign their business strategies.
  • The key findings and recommendations highlight crucial progressive industry trends in the global benign prostatic hyperplasic devices market, thereby allowing players across the value chain to develop effective long-term strategies.
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
  • Scrutinize in-depth global market trends and outlook coupled with the factors driving the benign prostatic hyperplasic devices market, as well as those hindering it.
  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing, and distribution.   

Table Of Contents

1. Introduction

  • 1.1 Scope of the Study
  • 1.2 The Insight Partners Research Report Guidance
  • 1.3 Market Segmentation
    • 1.3.1 Global Benign Prostatic Hyperplasic Devices Market - By Product
    • 1.3.2 Global Benign Prostatic Hyperplasic Devices Market - By Procedure Type
    • 1.3.3 Global Benign Prostatic Hyperplasic Devices Market - By End User
    • 1.3.4 Global Benign Prostatic Hyperplasic Devices Market - By Geography

2. Key Takeaways

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. Benign Prostatic Hyperplasic Devices Market - Market Landscape

  • 4.1 Overview
  • 4.2 PEST Analysis
    • 4.2.1 North America PEST Analysis
    • 4.2.2 Europe PEST Analysis
    • 4.2.3 Asia Pacific PEST Analysis
    • 4.2.4 Middle East And Africa PEST Analysis
    • 4.2.5 South And Central America PEST Analysis
  • 4.3 Experts Opinion

5. Benign Prostatic Hyperplasic Devices Market - Key Market Dynamics

  • 5.1 Market Drivers
    • 5.1.1 Increase in Prevalence of Benign Prostatic Hyperplasia along with Growing Risk Factors
    • 5.1.2 Rise in Investments, Funds, and Grants for Research in BPH Treatment
  • 5.2 Market Restraints
    • 5.2.1 Low Awareness of Prostate Health Among Men
  • 5.3 Market Opportunities
    • 5.3.1 Emerging Markets
  • 5.4 Future Trends
    • 5.4.1 Product Approvals and Launches
  • 5.5 Impact Analysis

6. Benign Prostatic Hyperplasic Devices Market - Global Analysis

  • 6.1 Global Benign Prostatic Hyperplasic Devices Market Revenue Forecast and Analysis
  • 6.2 Global Benign Prostatic Hyperplasic Devices Market, By Geography - Forecast and Analysis
  • 6.3 Global Benign Prostatic Hyperplasic Devices Market - Market Potential Analysis, By Region
  • 6.4 Company Analysis
    • 6.4.1 Market Positioning of Key Players
    • 6.4.2 Comparative Company Analysis
  • 6.5 Growth Strategy Analysis
  • 6.6 Performance of Key Players
    • 6.6.1 Olympus Corporation
    • 6.6.2 Butterfly Medical

7. Global Benign Prostatic Hyperplasic Devices Market Revenue and Forecast To 2028 - by Product

  • 7.1 Benign Prostatic Hyperplasic Devices Market Revenue Share, by Product (2022 and 2028)
  • 7.2 Resectoscopes
    • 7.2.1 Overview
    • 7.2.2 Resectoscopes: Benign Prostatic Hyperplasic Devices Market - Revenue and Forecast to 2028 (US$ Million)
  • 7.3 Urology Lasers
    • 7.3.1 Overview
    • 7.3.2 Urology Lasers: Benign Prostatic Hyperplasic Devices Market - Revenue and Forecast to 2028 (US$ Million)
  • 7.4 Radiofrequency Ablation Devices
    • 7.4.1 Overview
    • 7.4.2 Radiofrequency Ablation Devices: Benign Prostatic Hyperplasic Devices Market - Revenue and Forecast to 2028 (US$ Million)
  • 7.5 Prostatic Stents
    • 7.5.1 Overview
    • 7.5.2 Prostatic Stents: Benign Prostatic Hyperplasic Devices Market - Revenue and Forecast to 2028 (US$ Million)
  • 7.6 Implants
    • 7.6.1 Overview
    • 7.6.2 Implants: Benign Prostatic Hyperplasic Devices Market - Revenue and Forecast to 2028 (US$ Million)

8. Global Benign Prostatic Hyperplasic Devices Market Analysis and Forecast to 2028 - by Procedure Type

  • 8.1 Benign Prostatic Hyperplasic Devices Market Revenue Share, by Procedure Type (2022 and 2028)
  • 8.2 Transurethral Microwave Therapy
    • 8.2.1 Overview
    • 8.2.2 Transurethral Microwave Therapy: Benign Prostatic Hyperplasic Devices Market - Revenue and Forecast to 2028 (US$ Million)
  • 8.3 Transurethral Resection of the Prostate
    • 8.3.1 Overview
    • 8.3.2 Transurethral Resection of the Prostate: Benign Prostatic Hyperplasic Devices Market - Revenue and Forecast to 2028 (US$ Million)
  • 8.4 Transurethral Needle Ablation of the Prostate
    • 8.4.1 Overview
    • 8.4.2 Transurethral Needle Ablation of the Prostate: Benign Prostatic Hyperplasic Devices Market - Revenue and Forecast to 2028 (US$ Million)
  • 8.5 Laser Surgery
    • 8.5.1 Overview
    • 8.5.2 Laser Surgery: Benign Prostatic Hyperplasic Devices Market - Revenue and Forecast to 2028 (US$ Million)
  • 8.6 UroLift Surgery
    • 8.6.1 Overview
    • 8.6.2 UroLift Surgery: Benign Prostatic Hyperplasic Devices Market - Revenue and Forecast to 2028 (US$ Million)
  • 8.7 Others
    • 8.7.1 Overview
    • 8.7.2 Others: Benign Prostatic Hyperplasic Devices Market - Revenue and Forecast to 2028 (US$ Million)

9. Global Benign Prostatic Hyperplasic Devices Market Analysis and Forecast to 2028 - by End User

  • 9.1 Overview
  • 9.2 Benign Prostatic Hyperplasic Devices Market Revenue Share, by End User (2022 and 2028)
  • 9.3 Hospitals
    • 9.3.1 Overview
    • 9.3.2 Hospitals Market Revenue and Forecast to 2028 (US$ Million)
  • 9.4 Clinics
    • 9.4.1 Overview
    • 9.4.2 Clinics Market Revenue and Forecast to 2028 (US$ Million)
  • 9.5 Ambulatory Surgical Centers
    • 9.5.1 Overview
    • 9.5.2 Ambulatory Surgical Centers Market Revenue and Forecast to 2028 (US$ Million)
  • 9.6 Others
    • 9.6.1 Overview
    • 9.6.2 Others Market Revenue and Forecast to 2028 (US$ Million)

10. Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028 - Geographical Analysis

  • 10.1 North America: Benign Prostatic Hyperplasic Devices Market
    • 10.1.1 Overview
    • 10.1.2 North America: Benign Prostatic Hyperplasic Devices Market - Revenue and Forecast to 2028 (US$ Million)
    • 10.1.3 North America: Benign Prostatic Hyperplasic Devices Market, by Product, 2019-2028 (US$ Million)
    • 10.1.4 North America: Benign Prostatic Hyperplasic Devices Market, by Procedure Type, 2019-2028 (US$ Million)
    • 10.1.5 North America: Benign Prostatic Hyperplasic Devices Market, by End User, 2019-2028 (US$ Million)
    • 10.1.6 North America: Benign Prostatic Hyperplasic Devices Market, by Country, 2022 & 2028 (%)
      • 10.1.6.1 US: Benign Prostatic Hyperplasic Devices Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.1.6.1.1 Overview
        • 10.1.6.1.2 US: Benign Prostatic Hyperplasic Devices Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.1.6.1.3 US: Benign Prostatic Hyperplasic Devices Market, by Product, 2019-2028 (US$ Million)
        • 10.1.6.1.4 US: Benign Prostatic Hyperplasic Devices Market, by Procedure Type, 2019-2028 (US$ Million)
        • 10.1.6.1.5 US: Benign Prostatic Hyperplasic Devices Market, by End User, 2019-2028 (US$ Million)
      • 10.1.6.2 Canada: Benign Prostatic Hyperplasic Devices Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.1.6.2.1 Overview
        • 10.1.6.2.2 Canada: Benign Prostatic Hyperplasic Devices Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.1.6.2.3 Canada: Benign Prostatic Hyperplasic Devices Market, by Product, 2019-2028 (US$ Million)
        • 10.1.6.2.4 Canada: Benign Prostatic Hyperplasic Devices Market, by Procedure Type, 2019-2028 (US$ Million)
        • 10.1.6.2.5 Canada: Benign Prostatic Hyperplasic Devices Market, by End User, 2019-2028 (US$ Million)
      • 10.1.6.3 Mexico: Benign Prostatic Hyperplasic Devices Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.1.6.3.1 Overview
        • 10.1.6.3.2 Mexico: Benign Prostatic Hyperplasic Devices Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.1.6.3.3 Mexico: Benign Prostatic Hyperplasic Devices Market, by Product, 2019-2028 (US$ Million)
        • 10.1.6.3.4 Mexico: Benign Prostatic Hyperplasic Devices Market, by Procedure Type, 2019-2028 (US$ Million)
        • 10.1.6.3.5 Mexico: Benign Prostatic Hyperplasic Devices Market, by End User, 2019-2028 (US$ Million)
  • 10.2 Europe: Benign Prostatic Hyperplasic Devices Market
    • 10.2.1 Overview
    • 10.2.2 Europe: Benign Prostatic Hyperplasic Devices Market - Revenue and Forecast to 2028 (US$ Million)
    • 10.2.3 Europe: Benign Prostatic Hyperplasic Devices Market, by Product- Revenue and Forecast to 2028 (US$ Million)
    • 10.2.4 Europe: Benign Prostatic Hyperplasic Devices Market, by Procedure Type - Revenue and Forecast to 2028 (US$ Million)
    • 10.2.5 Europe: Benign Prostatic Hyperplasic Devices Market, by End User - Revenue and Forecast to 2028 (US$ Million)
    • 10.2.6 Europe: Benign Prostatic Hyperplasic Devices Market, by Country, 2022 & 2028 (%)
      • 10.2.6.1 UK: Benign Prostatic Hyperplasic Devices Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.2.6.1.1 Overview
        • 10.2.6.1.2 UK: Benign Prostatic Hyperplasic Devices Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.2.6.1.3 UK: Benign Prostatic Hyperplasic Devices Market, by Product- Revenue and Forecast to 2028 (US$ Million)
        • 10.2.6.1.4 UK: Benign Prostatic Hyperplasic Devices Market, by Procedure Type - Revenue and Forecast to 2028 (US$ Million)
        • 10.2.6.1.5 UK: Benign Prostatic Hyperplasic Devices Market, by End User - Revenue and Forecast to 2028 (US$ Million)
      • 10.2.6.2 Germany: Benign Prostatic Hyperplasic Devices Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.2.6.2.1 Overview
        • 10.2.6.2.2 Germany: Benign Prostatic Hyperplasic Devices Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.2.6.2.3 Germany: Benign Prostatic Hyperplasic Devices Market, by Product- Revenue and Forecast to 2028 (US$ Million)
        • 10.2.6.2.4 Germany: Benign Prostatic Hyperplasic Devices Market, by Procedure Type - Revenue and Forecast to 2028 (US$ Million)
        • 10.2.6.2.5 Germany: Benign Prostatic Hyperplasic Devices Market, by End User - Revenue and Forecast to 2028 (US$ Million)
      • 10.2.6.3 France: Benign Prostatic Hyperplasic Devices Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.2.6.3.1 Overview
        • 10.2.6.3.2 France: Benign Prostatic Hyperplasic Devices Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.2.6.3.3 France: Benign Prostatic Hyperplasic Devices Market, by Product- Revenue and Forecast to 2028 (US$ Million)
        • 10.2.6.3.4 France: Benign Prostatic Hyperplasic Devices Market, by Procedure Type - Revenue and Forecast to 2028 (US$ Million)
        • 10.2.6.3.5 France: Benign Prostatic Hyperplasic Devices Market, by End User - Revenue and Forecast to 2028 (US$ Million)
      • 10.2.6.4 Italy: Benign Prostatic Hyperplasic Devices Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.2.6.4.1 Overview
        • 10.2.6.4.2 Italy: Benign Prostatic Hyperplasic Devices Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.2.6.4.3 Italy: Benign Prostatic Hyperplasic Devices Market, by Product- Revenue and Forecast to 2028 (US$ Million)
        • 10.2.6.4.4 Italy: Benign Prostatic Hyperplasic Devices Market, by Procedure Type - Revenue and Forecast to 2028 (US$ Million)
        • 10.2.6.4.5 Italy: Benign Prostatic Hyperplasic Devices Market, by End User - Revenue and Forecast to 2028 (US$ Million)
      • 10.2.6.5 Spain: Benign Prostatic Hyperplasic Devices Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.2.6.5.1 Overview
        • 10.2.6.5.2 Spain: Benign Prostatic Hyperplasic Devices Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.2.6.5.3 Spain: Benign Prostatic Hyperplasic Devices Market, by Product- Revenue and Forecast to 2028 (US$ Million)
        • 10.2.6.5.4 Spain: Benign Prostatic Hyperplasic Devices Market, by Procedure Type - Revenue and Forecast to 2028 (US$ Million)
        • 10.2.6.5.5 Spain: Benign Prostatic Hyperplasic Devices Market, by End User - Revenue and Forecast to 2028 (US$ Million)
      • 10.2.6.6 Rest of Europe: Benign Prostatic Hyperplasic Devices Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.2.6.6.1 Overview
        • 10.2.6.6.2 Rest of Europe: Benign Prostatic Hyperplasic Devices Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.2.6.6.3 Rest of Europe: Benign Prostatic Hyperplasic Devices Market, by Product- Revenue and Forecast to 2028 (US$ Million)
        • 10.2.6.6.4 Rest of Europe: Benign Prostatic Hyperplasic Devices Market, by Procedure Type - Revenue and Forecast to 2028 (US$ Million)
        • 10.2.6.6.5 Rest of Europe: Benign Prostatic Hyperplasic Devices Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • 10.3 Asia Pacific Benign Prostatic Hyperplasic Devices Market Revenue and Forecast To 2028
    • 10.3.1 Overview
    • 10.3.2 Asia Pacific Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028 (US$ Million)
    • 10.3.3 Asia Pacific: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028, By Product (US$ Million)
    • 10.3.4 Asia Pacific: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028, By Procedure Type (US$ Million)
    • 10.3.5 Asia Pacific: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028, By End User (US$ Million)
    • 10.3.6 Asia Pacific: Benign Prostatic Hyperplasic Devices Market, by Country, 2022 & 2028 (%)
      • 10.3.6.1 China: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028 (US$ Million)
        • 10.3.6.1.1 Overview
        • 10.3.6.1.2 China: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028 (US$ Million)
        • 10.3.6.1.3 China: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028, By Product (US$ Million)
        • 10.3.6.1.4 China: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028, By Procedure Type (US$ Million)
        • 10.3.6.1.5 China: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028, By End User (US$ Million)
      • 10.3.6.2 Japan: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028 (US$ Million)
        • 10.3.6.2.1 Overview
        • 10.3.6.2.2 Japan: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028 (US$ Million)
        • 10.3.6.2.3 Japan: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028, By Product (US$ Million)
        • 10.3.6.2.4 Japan: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028, By Procedure Type (US$ Million)
        • 10.3.6.2.5 Japan: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028, By End User (US$ Million)
      • 10.3.6.3 India Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028 (US$ Million)
        • 10.3.6.3.1 Overview
        • 10.3.6.3.2 India: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028 (US$ Million)
        • 10.3.6.3.3 India: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028, By Product (US$ Million)
        • 10.3.6.3.4 India: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028, By Procedure Type (US$ Million)
        • 10.3.6.3.5 India: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028, By End User (US$ Million)
      • 10.3.6.4 South Korea: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028 (US$ Million)
        • 10.3.6.4.1 Overview
        • 10.3.6.4.2 South Korea: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028 (US$ Million)
        • 10.3.6.4.3 South Korea: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028, By Product (US$ Million)
        • 10.3.6.4.4 South Korea: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028, By Procedure Type (US$ Million)
        • 10.3.6.4.5 South Korea: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028, By End User (US$ Million)
      • 10.3.6.5 Australia: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028 (US$ Million)
        • 10.3.6.5.1 Overview
        • 10.3.6.5.2 Australia: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028 (US$ Million)
        • 10.3.6.5.3 Australia: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028, By Product (US$ Million)
        • 10.3.6.5.4 Australia: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028, By Procedure Type (US$ Million)
        • 10.3.6.5.5 Australia: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028, By End User (US$ Million)
      • 10.3.6.6 Rest of Asia Pacific: Benign Prostatic Hyperplasic Devices Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.3.6.6.1 Overview
        • 10.3.6.6.2 Rest of Asia Pacific: Benign Prostatic Hyperplasic Devices Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.3.6.6.3 Rest of Asia Pacific: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028, By Product (US$ Million)
        • 10.3.6.6.4 Rest of Asia Pacific: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028, By Procedure Type (US$ Million)
        • 10.3.6.6.5 Rest of Asia Pacific: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028, By End User (US$ Million)
  • 10.4 Middle East & Africa Benign Prostatic Hyperplasic Devices Market Revenue and Forecast To 2028
    • 10.4.1 Overview
    • 10.4.2 Middle East & Africa Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028 (US$ Million)
    • 10.4.3 Middle East & Africa: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028, By Product (US$ Million)
    • 10.4.4 Middle East & Africa: Metabolomics Market Revenue and Forecast to 2028, By Procedure Type (US$ Million)
    • 10.4.5 Middle East & Africa: Metabolomics Market Revenue and Forecast to 2028, By End User (US$ Million)
    • 10.4.6 Middle East & Africa: Benign Prostatic Hyperplasic Devices Market, by Country, 2022 & 2028 (%)
      • 10.4.6.1 Saudi Arabia: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028 (US$ Million)
        • 10.4.6.1.1 Overview
        • 10.4.6.1.2 Saudi Arabia: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028 (US$ Million)
        • 10.4.6.1.3 Saudi Arabia: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028, By Product (US$ Million)
        • 10.4.6.1.4 Saudi Arabia: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast To 2028, By Procedure Type (US$ Million)
        • 10.4.6.1.5 Saudi Arabia: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast To 2028, By End User (US$ Million)
      • 10.4.6.2 South Africa: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028 (US$ Million)
        • 10.4.6.2.1 Overview
        • 10.4.6.2.2 South Africa Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028 (US$ Million)
        • 10.4.6.2.3 South Africa: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028, By Product (US$ Million)
        • 10.4.6.2.4 South Africa: Metabolomics Market Revenue and Forecast To 2028, By Procedure Type (US$ Million)
        • 10.4.6.2.5 South Africa: Metabolomics Market Revenue and Forecast To 2028, By Procedure Type (US$ Million)
      • 10.4.6.3 UAE: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028 (US$ Million)
        • 10.4.6.3.1 Overview
        • 10.4.6.3.2 UAE: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028 (US$ Million)
        • 10.4.6.3.3 UAE: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028, By Product (US$ Million)
        • 10.4.6.3.4 UAE: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast To 2028, By Procedure Type (US$ Million)
        • 10.4.6.3.5 UAE: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast To 2028, By End User (US$ Million)
      • 10.4.6.4 Rest of Middle East and Africa: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028 (US$ Million)
        • 10.4.6.4.1 Overview
        • 10.4.6.4.2 Rest of Middle East and Africa: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028 (US$ Million)
        • 10.4.6.4.3 Rest of Middle East & Africa: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028, By Product (US$ Million)
        • 10.4.6.4.4 Rest of Middle East & Africa: Metabolomics Market Revenue and Forecast To 2028, By Procedure Type (US$ Million)
        • 10.4.6.4.5 Rest of Middle East & Africa: Metabolomics Market Revenue and Forecast To 2028, By End User (US$ Million)
  • 10.5 South And Central America Benign Prostatic Hyperplasic Devices Market Revenue and Forecast To 2028
    • 10.5.1 Overview
    • 10.5.2 South and Central America Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028 (US$ Million)
    • 10.5.3 South and Central America Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028, By Product (US$ Million)
    • 10.5.4 South and Central America: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028, By Procedure Type (US$ Million)
    • 10.5.5 South and Central America: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028, By End User (US$ Million)
    • 10.5.6 South and Central America: Benign Prostatic Hyperplasic Devices Market, by Country, 2022 & 2028 (%)
      • 10.5.6.1 Brazil: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028 (US$ Million)
        • 10.5.6.1.1 Overview
        • 10.5.6.1.2 Brazil: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028 (US$ Million)
        • 10.5.6.1.3 Brazil: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028, By Product (US$ Million)
        • 10.5.6.1.4 Brazil: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast To 2028, By Procedure Type (US$ Million)
        • 10.5.6.1.5 Brazil: Benign Prostatic Hyperplasic Devices Market, by End User - Revenue and Forecast to 2028 (US$ Million)
      • 10.5.6.2 Argentina Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028 (US$ Million)
        • 10.5.6.2.1 Overview
        • 10.5.6.2.2 Argentina Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028 (US$ Million)
        • 10.5.6.2.3 Argentina: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028, By Product (US$ Million)
        • 10.5.6.2.4 Argentina: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast To 2028, By Procedure Type (US$ Million)
        • 10.5.6.2.5 Argentina: Benign Prostatic Hyperplasic Devices Market, by End User - Revenue and Forecast to 2028 (US$ Million)
      • 10.5.6.3 Rest of South and Central America: Benign Prostatic Hyperplasic Devices Market- Revenue and Forecast to 2028 (USD Mn)
        • 10.5.6.3.1 Overview
        • 10.5.6.3.2 Rest of South and Central America: Benign Prostatic Hyperplasic Devices Market- Revenue and Forecast to 2028 (USD Mn)
        • 10.5.6.3.3 Rest of South & Central America: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028, By Product (US$ Million)
        • 10.5.6.3.4 Rest of South & Central America: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast To 2028, By Procedure Type (US$ Million)
        • 10.5.6.3.5 Rest of South and Central America: Benign Prostatic Hyperplasic Devices Market, by End User - Revenue and Forecast to 2028 (US$ Million)

11. Impact Of COVID-19 Pandemic on Benign Prostatic Hyperplasic Devices Market

  • 11.1 North America: Impact Assessment of COVID-19 Pandemic
  • 11.2 Europe: Impact Assessment of COVID-19 Pandemic
  • 11.3 Asia Pacific: Impact Assessment of COVID-19 Pandemic
  • 11.4 Middle East and Africa: Impact Assessment of COVID-19 Pandemic
  • 11.5 South and Central America: Impact Assessment of COVID-19 Pandemic

12. Benign Prostatic Hyperplasic Devices Market - Industry Landscape

  • 12.1 Overview
  • 12.2 Growth Strategies in the Benign Prostatic Hyperplasia Devices Market
  • 12.3 Inorganic Growth Strategies
  • 12.4 Organic Growth Strategies

13. Company Profiles

  • 13.1 KARL STORZ SE & Co. KG
    • 13.1.1 Key Facts
    • 13.1.2 Business Description
    • 13.1.3 Products and Services
    • 13.1.4 Financial Overview
    • 13.1.5 SWOT Analysis
    • 13.1.6 Key Developments
  • 13.2 Richard Wolf GmbH
    • 13.2.1 Key Facts
    • 13.2.2 Business Description
    • 13.2.3 Products and Services
    • 13.2.4 Financial Overview
    • 13.2.5 SWOT Analysis
    • 13.2.6 Key Developments
  • 13.3 Olympus Corporation
    • 13.3.1 Key Facts
    • 13.3.2 Business Description
    • 13.3.3 Products and Services
    • 13.3.4 Financial Overview
    • 13.3.5 SWOT Analysis
    • 13.3.6 Key Developments
  • 13.4 Urologix, LLC.
    • 13.4.1 Key Facts
    • 13.4.2 Business Description
    • 13.4.3 Products and Services
    • 13.4.4 Financial Overview
    • 13.4.5 SWOT Analysis
    • 13.4.6 Key Developments
  • 13.5 Boston Scientific Corporation
    • 13.5.1 Key Facts
    • 13.5.2 Business Description
    • 13.5.3 Products and Services
    • 13.5.4 Financial Overview
    • 13.5.5 SWOT Analysis
    • 13.5.6 Key Developments
  • 13.6 Butterfly
    • 13.6.1 Key Facts
    • 13.6.2 Business Description
    • 13.6.3 Products and Services
    • 13.6.4 Financial Overview
    • 13.6.5 SWOT Analysis
    • 13.6.6 Key Developments
  • 13.7 Teleflex Incorporated
    • 13.7.1 Key Facts
    • 13.7.2 Business Description
    • 13.7.3 Products and Services
    • 13.7.4 Financial Overview
    • 13.7.5 SWOT Analysis
    • 13.7.6 Key Developments
  • 13.8 OmniGuide Holdings, Inc.
    • 13.8.1 Key Facts
    • 13.8.2 Business Description
    • 13.8.3 Products and Services
    • 13.8.4 Financial Overview
    • 13.8.5 SWOT Analysis
    • 13.8.6 Key Developments
  • 13.9 Convergent Laser Technologies
    • 13.9.1 Key Facts
    • 13.9.2 Business Description
    • 13.9.3 Products and Services
    • 13.9.4 Financial Overview
    • 13.9.5 SWOT Analysis
    • 13.9.6 Key Developments
  • 13.10 ProArc
    • 13.10.1 Key Facts
    • 13.10.2 Business Description
    • 13.10.3 Products and Services
    • 13.10.4 Financial Overview
    • 13.10.5 SWOT Analysis
    • 13.10.6 Key Developments

14. Appendix

  • 14.1 About The Insight Partners
  • 14.2 Glossary of Terms for Benign Prostatic Hyperplasia Devices Market

List Of Tables

  • Table 1. North America Benign Prostatic Hyperplasic Devices Market, by Product- Revenue and Forecast to 2028 (USD Million)
  • Table 2. North America Benign Prostatic Hyperplasic Devices Market, by Procedure Type- Revenue and Forecast to 2028 (US$ Million)
  • Table 3. North America Benign Prostatic Hyperplasic Devices Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 4. US Benign Prostatic Hyperplasic Devices Market, by Product- Revenue and Forecast to 2028 (US$ Million)
  • Table 5. US Benign Prostatic Hyperplasic Devices Market, by Procedure Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 6. US Benign Prostatic Hyperplasic Devices Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 7. Canada Benign Prostatic Hyperplasic Devices Market, by Product- Revenue and Forecast to 2028 (US$ Million)
  • Table 8. Canada Benign Prostatic Hyperplasic Devices Market, by Procedure Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 9. Canada Benign Prostatic Hyperplasic Devices Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 10. Mexico Benign Prostatic Hyperplasic Devices Market, by Product- Revenue and Forecast to 2028 (US$ Million)
  • Table 11. Mexico Benign Prostatic Hyperplasic Devices Market, by Procedure Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 12. Mexico Benign Prostatic Hyperplasic Devices Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 13. Europe: Benign Prostatic Hyperplasic Devices Market, by Product- Revenue and Forecast to 2028 (US$ Million)
  • Table 14. Europe: Benign Prostatic Hyperplasic Devices Market, by Procedure Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 15. Europe: Benign Prostatic Hyperplasic Devices Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 16. UK: Benign Prostatic Hyperplasic Devices Market, by Product- Revenue and Forecast to 2028 (US$ Million)
  • Table 17. UK: Benign Prostatic Hyperplasic Devices Market, by Procedure Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 18. UK: Benign Prostatic Hyperplasic Devices Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 19. Germany: Benign Prostatic Hyperplasic Devices Market, by Product- Revenue and Forecast to 2028 (US$ Million)
  • Table 20. Germany: Benign Prostatic Hyperplasic Devices Market, by Procedure Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 21. Germany: Benign Prostatic Hyperplasic Devices Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 22. France: Benign Prostatic Hyperplasic Devices Market, by Product- Revenue and Forecast to 2028 (US$ Million)
  • Table 23. France: Benign Prostatic Hyperplasic Devices Market, by Procedure Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 24. France: Benign Prostatic Hyperplasic Devices Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 25. Italy: Benign Prostatic Hyperplasic Devices Market, by Product- Revenue and Forecast to 2028 (US$ Million)
  • Table 26. Italy: Benign Prostatic Hyperplasic Devices Market, by Procedure Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 27. Italy: Benign Prostatic Hyperplasic Devices Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 28. Spain: Benign Prostatic Hyperplasic Devices Market, by Product- Revenue and Forecast to 2028 (US$ Million)
  • Table 29. Spain: Benign Prostatic Hyperplasic Devices Market, by Procedure Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 30. Spain: Benign Prostatic Hyperplasic Devices Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 31. Rest of Europe: Benign Prostatic Hyperplasic Devices Market, by Product- Revenue and Forecast to 2028 (US$ Million)
  • Table 32. Rest of Europe: Benign Prostatic Hyperplasic Devices Market, by Procedure Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 33. Rest of Europe: Benign Prostatic Hyperplasic Devices Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 34. Asia Pacific: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028, By Product (US$ Million).
  • Table 35. Asia Pacific: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028, By Procedure Type (US$ Million)
  • Table 36. Asia Pacific: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028, By End User (US$ Million)
  • Table 37. China: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028, By Product (US$ Million)
  • Table 38. China: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028, By Procedure Type (US$ Million)
  • Table 39. China: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028, By End User (US$ Million)
  • Table 40. Japan: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028, By Product (US$ Million)
  • Table 41. Japan: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028, By Procedure Type (US$ Million)
  • Table 42. Japan: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028, By End User (US$ Million)
  • Table 43. India: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028, By Product (US$ Million)
  • Table 44. India: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028, By Procedure Type (US$ Million)
  • Table 45. India: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028, By End User (US$ Million)
  • Table 46. South Korea: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028, By Product (US$ Million)
  • Table 47. South Korea: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028, By Procedure Type (US$ Million)
  • Table 48. South Korea: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028, By End User (US$ Million)
  • Table 49. Australia: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028, By Product (US$ Million)
  • Table 50. Australia: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028, By Procedure Type (US$ Million)
  • Table 51. Australia: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028, By End User (US$ Million)
  • Table 52. Rest of Asia Pacific: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028, By Product (US$ Million)
  • Table 53. Rest of Asia Pacific: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028, By Procedure Type (US$ Million)
  • Table 54. Rest of Asia Pacific: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028, By End User (US$ Million)
  • Table 55. Middle East & Africa: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028, By Product (US$ Million)
  • Table 56. Middle East & Africa: Metabolomics Market Revenue and Forecast to 2028, By Procedure Type (US$ Million)
  • Table 57. Middle East & Africa: Metabolomics Market Revenue and Forecast to 2028, By End User (US$ Million)
  • Table 58. Saudi Arabia: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028, By Product (US$ Million)
  • Table 59. Saudi Arabia: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028, By Procedure Type (US$ Million)
  • Table 60. Saudi Arabia: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028, By End User (US$ Million)
  • Table 61. South Africa Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028, By Product (US$ Million)
  • Table 62. South Africa: Metabolomics Market Revenue and Forecast to 2028, By Procedure Type (US$ Million)
  • Table 63. South Africa: Metabolomics Market Revenue and Forecast to 2028, By Procedure Type (US$ Million)
  • Table 64. UAE: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028, By Product (US$ Million)
  • Table 65. UAE: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028, By Procedure Type (US$ Million)
  • Table 66. UAE: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028, By End User (US$ Million)
  • Table 67. Rest of Middle East & Africa: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028, By Product (US$ Million)
  • Table 68. Rest of Middle East & Africa: Metabolomics Market Revenue and Forecast to 2028, By Procedure Type (US$ Million)
  • Table 69. Rest of Middle East & Africa: Metabolomics Market Revenue and Forecast to 2028, By End User (US$ Million)
  • Table 70. South and Central America Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028, By Product (US$ Million)
  • Table 71. South and Central America: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028, By Procedure Type (US$ Million)
  • Table 72. South and Central America: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028, By End User (US$ Million)
  • Table 73. Brazil: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028, By Product (US$ Million)
  • Table 74. Brazil: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028, By Procedure Type (US$ Million)
  • Table 75. Brazil: Benign Prostatic Hyperplasic Devices Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 76. Argentina: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028, By Product (US$ Million)
  • Table 77. Argentina: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028, By Procedure Type (US$ Million)
  • Table 78. Argentina: Benign Prostatic Hyperplasic Devices Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 79. Rest of South & Central America: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028, By Product (US$ Million)
  • Table 80. Rest of South & Central America: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028, By Procedure Type (US$ Million)
  • Table 81. Rest of South and Central America: Benign Prostatic Hyperplasic Devices Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 82. Recent Inorganic Growth Strategies in the Benign Prostatic Hyperplasia Devices Market
  • Table 83. Recent Organic Growth Strategies in the Benign Prostatic Hyperplasia Devices Market
  • Table 84. Glossary of Terms

List Of Figures

  • Figure 1. Benign Prostatic Hyperplasic Devices Market Segmentation
  • Figure 2. Benign Prostatic Hyperplasic Devices Market, By Region
  • Figure 3. Global Benign Prostatic Hyperplasic Devices Market Overview
  • Figure 4. Resectoscopes Segment Held Largest Share of Product Segment in Benign Prostatic Hyperplasic Devices Market
  • Figure 5. Asia Pacific is Expected to Show Remarkable Growth During the Forecast Period
  • Figure 6. Benign Prostatic Hyperplasic Devices Market, by Geography (US$ Million)
  • Figure 7. Global Benign Prostatic Hyperplasic Devices Market- Leading Country Markets (US$ Million)
  • Figure 8. Global Benign Prostatic Hyperplasic Devices Market, Industry Landscape
  • Figure 9. North America: PEST Analysis
  • Figure 10. Europe: PEST Analysis
  • Figure 11. Asia Pacific: PEST Analysis
  • Figure 12. Middle East And Africa: PEST Analysis
  • Figure 13. South And Central America: PEST Analysis
  • Figure 14. Experts Opinion
  • Figure 15. Global Benign Prostatic Hyperplasic Devices Market - Revenue Forecast and Analysis - 2020-2028
  • Figure 16. Global Benign Prostatic Hyperplasic Devices Market - By Geography Forecast and Analysis - 2022- 2028
  • Figure 17. Global Benign Prostatic Hyperplasic Devices Market - Market Potential Analysis, By Region
  • Figure 18. Market Positioning of Key Players In Global Benign Prostatic Hyperplasic Devices Market
  • Figure 19. Global Benign Prostatic Hyperplasic Devices Market - Comparative Company Analysis
  • Figure 20. Global Benign Prostatic Hyperplasic Devices Market - Growth Strategy Analysis
  • Figure 21. Benign Prostatic Hyperplasic Devices Market Revenue Share, by Product (2022 and 2028)
  • Figure 22. Resectoscopes: Benign Prostatic Hyperplasic Devices Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 23. Urology Lasers: Benign Prostatic Hyperplasic Devices Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 24. Radiofrequency Ablation Devices: Benign Prostatic Hyperplasic Devices Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 25. Prostatic Stents: Benign Prostatic Hyperplasic Devices Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 26. Implants: Benign Prostatic Hyperplasic Devices Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 27. Benign Prostatic Hyperplasic Devices Market Revenue Share, by Procedure Type (2022 and 2028)
  • Figure 28. Transurethral Microwave Therapy: Benign Prostatic Hyperplasic Devices Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 29. Transurethral Resection of the Prostate: Benign Prostatic Hyperplasic Devices Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 30. Transurethral Needle Ablation of the Prostate: Benign Prostatic Hyperplasic Devices Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 31. Laser Surgery: Benign Prostatic Hyperplasic Devices Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 32. UroLift Surgery: Benign Prostatic Hyperplasic Devices Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 33. Others: Benign Prostatic Hyperplasic Devices Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 34. Benign Prostatic Hyperplasic Devices Market Revenue Share, by End User (2022 and 2028)
  • Figure 35. Hospitals Market Revenue and Forecast to 2028 (US$ Million)
  • Figure 36. Clinics Market Revenue and Forecast to 2028 (US$ Million)
  • Figure 37. Ambulatory Surgical Centers Market Revenue and Forecast to 2028 (US$ Million)
  • Figure 38. Others Market Revenue and Forecast to 2028 (US$ Million)
  • Figure 39. North America: Benign Prostatic Hyperplasic Devices Market, by Key Country - Revenue (2022) (US$ Million)
  • Figure 40. North America Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028 (US$ Million)
  • Figure 41. North America: Benign Prostatic Hyperplasic Devices Market, by Country, 2022 & 2028 (%)
  • Figure 42. US: Benign Prostatic Hyperplasic Devices Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 43. Canada: Benign Prostatic Hyperplasic Devices Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 44. Mexico: Benign Prostatic Hyperplasic Devices Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 45. Europe: Benign Prostatic Hyperplasic Devices Market, by Key Country - Revenue (2022) (US$ Million)
  • Figure 46. Europe: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028 (US$ Million)
  • Figure 47. Europe: Benign Prostatic Hyperplasic Devices Market, by Country, 2022 & 2028 (%)
  • Figure 48. UK: Benign Prostatic Hyperplasic Devices Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 49. Germany: Benign Prostatic Hyperplasic Devices Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 50. France: Benign Prostatic Hyperplasic Devices Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 51. Italy: Benign Prostatic Hyperplasic Devices Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 52. Spain: Benign Prostatic Hyperplasic Devices Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 53. Rest of Europe: Benign Prostatic Hyperplasic Devices Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 54. Asia Pacific Benign Prostatic Hyperplasic Devices Market Overview, by Country (2021)
  • Figure 55. Asia Pacific: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028 (US$ Million)
  • Figure 56. Asia Pacific: Benign Prostatic Hyperplasic Devices Market, by Country, 2022 & 2028 (%)
  • Figure 57. China: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028 (US$ Million)
  • Figure 58. Japan: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028 (US$ Million)
  • Figure 59. India: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028 (US$ Million)
  • Figure 60. South Korea: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028 (US$ Million)
  • Figure 61. Australia: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028 (US$ Million)
  • Figure 62. Rest of Asia Pacific: Benign Prostatic Hyperplasic Devices Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 63. Middle East & Africa Benign Prostatic Hyperplasic Devices Market Revenue Overview, by Country, 2021 (US$ Million)
  • Figure 64. Middle East & Africa Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028 (US$ Million)
  • Figure 65. Middle East & Africa: Benign Prostatic Hyperplasic Devices Market, by Country, 2022 & 2028 (%)
  • Figure 66. Saudi Arabia: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028 (US$ Million)
  • Figure 67. South Africa: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028 (US$ Million)
  • Figure 68. UAE: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028 (US$ Million)
  • Figure 69. Rest of Middle East and Africa: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028 (US$ Million)
  • Figure 70. South and Central America Benign Prostatic Hyperplasic Devices Market Revenue Overview, by Country, 2021 (US$ Million)
  • Figure 71. South and Central America Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028 (US$ Million)
  • Figure 72. South and Central America: Benign Prostatic Hyperplasic Devices Market, by Country, 2022 & 2028 (%)
  • Figure 73. Brazil: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028 (US$ Million)
  • Figure 74. Argentina Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028 (US$ Million)
  • Figure 75. Rest of South and Central America: Benign Prostatic Hyperplasic Devices Market- Revenue and Forecast to 2028 (USD Mn)
  • Figure 76. Impact of COVID-19 Pandemic in North American Country Markets
  • Figure 77. Impact of COVID-19 Pandemic in European Country Markets
  • Figure 78. Impact of COVID-19 Pandemic in Asia Pacific Country Markets
  • Figure 79. Impact of COVID-19 Pandemic in Middle East and Africa Country Markets
  • Figure 80. Impact Of COVID-19 Pandemic in South and Central America Country Markets